As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

The company does not expect the ruling to impact outcomes of its patent infringement cases against Moderna. Arbutus Biopharma ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

Life on our planet emerged quickly or, at least, it did so on a geological timescale. Fossils reveal that micro-life existed on our planet at least 3.5 billion years ago. The rapid emergence of life ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...

A group of leading health experts, legal professionals and patient advocates on Wednesday underscored the urgent need for ...

A device capable of conveniently detecting pathogens in healthcare, food production and agricultural environments has been ...

MicroRNAs play a central role in controlling gene expression, yet how cells select the active strand from each microRNA precursor has remained unclear. In this study, ASU researchers demonstrate that ...

Guanidine is an organic compound primarily used as a denaturing reagent to disrupt the structures of proteins and nucleic ...

Triana Biomedicines Inc. has divulged protein/nucleic acid degraders acting as cyclin-dependent kinase 2 (CDK2) degraders reported to be useful for the treatment of cancer.